These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11443118)

  • 1. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
    Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
    J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.
    Chin H; Saito T; Arai A; Yamamoto K; Kamiyama R; Miyasaka N; Miura O
    Biochem Biophys Res Commun; 1997 Oct; 239(2):412-7. PubMed ID: 9344843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CrkL mediates Ras-dependent activation of the Raf/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3.
    Nosaka Y; Arai A; Miyasaka N; Miura O
    J Biol Chem; 1999 Oct; 274(42):30154-62. PubMed ID: 10514505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
    Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
    Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
    Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional interaction between p72(syk) and erythropoietin receptor.
    Duprez V; Blank U; Chrétien S; Gisselbrecht S; Mayeux P
    J Biol Chem; 1998 Dec; 273(51):33985-90. PubMed ID: 9852052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells.
    Kanda E; Jin ZH; Mizuchi D; Arai A; Miura O
    Biochem Biophys Res Commun; 2003 Feb; 301(4):934-40. PubMed ID: 12589802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
    Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
    J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
    Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
    Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
    Miura Y; Miura O; Ihle JN; Aoki N
    J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
    Arai A; Aoki M; Weihua Y; Jin A; Miura O
    Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
    Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
    J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL; Mason JM; Fukazawa T; Reedquist KA; Druker BJ; Band H; D'Andrea AD
    Blood; 1997 May; 89(9):3166-74. PubMed ID: 9129019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.